ArticleEuropean journal of haematology2019

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma.

Kenji Ishitsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.